Contrary to your experience, I actually enjoy placing the device. The patients comments have been that the stylet seems sharper and therefore it doesn't hurt as much. There is definitely a learning curve to it but with the proper training, I think anyone could get used to it.
The FDA product recalls were probably from initial design of 2003. BD has then redesigned the product. I am not a paid speaker for BD but I can see where everyone could benefit from this product. We concluded a 3-week trial with very good results. I would like to see where you got the product recall information from and ask my BD rep about it. Thanks.
Angelo M. Aguila, MSN, RN, VA-BC
Vascular Access Nurse[email protected]
We had the EXACT same experience concerning the Nexiva catheters ! It has to make you wonder what type of sales hype is being given that these catheters are railroaded in, even after feedback states that the learning curve is long and we find them not to be patient friendly. We, on the IV team were asked to "trial" them for consideration, wrote out the paperwork with our assessment of the catheter and were told by the powers that be to "get used to them, the whole hospital will be going to them next week and all others will be removed." So much for a trial. The decision had been made long before we even knew they were coming. It took us a year to have decent skill & competency using these catheters (the IV team, the rest of the hospital & ancillary dept.'s still can't do them). We were lucky in being able to keep a small supply of our previous IV's (agreed to by product division, not the nursing supervisory staff) for those with difficult veins. My biggest complaint is the discomfort and pain caused to the patient. 90% of my patients complain that they are very painful during insertion-----the rep replied that these catheters are actually sharper than our Bard Insytes----therefore it must be our techniques, and when that improved there would be no problem. Phooie! I find them to be less manuverable, less pliant, duller & more painful. Unless I have a large straight "easy" vein I revert back to my old standby, particually in the elderly or chronicly ill patients . Let me know how your doing? I'm finally getting the hang of it but it's still not my first choice of equipment and i always have Bard Insytes on the cart. We were told not to use them on pediatric patients under the age of ?6yrs--i could be wrong on the age factor, i'd have to recheck that. so we didn't have to many problems with the pediatric population getting multiple sticks. The whole way it was presented, introduced and the forced change without proper investigation or trial----smells political to me & it stinks.
Sorry you had this problem, but you have misstated one thing. Bard does not manufacturer or sell a short peripheral IV catheter. Insyte is the trademane for the short peripheral catheter made by BD, the same manufacturer as the Nexiva. Insyte Autogard is the trade name for the BD catheter with a safety mechanism. Bard makes all other types of catheter but not a short periperhal one.
Lynn Hadaway, M.Ed., NPD-BC, CRNI
Lynn Hadaway Associates, Inc.
PO Box 10
Milner, GA 30257
Office Phone 770-358-7861
Also sorry you have had problems especiallly with the materials management side of it. I would advise you to join the product assessment team (whomever makes these decisions). It makes advocating for or against a product much easier and more effective.
We have been using the Nexiva for several years now (think we were a beta site). It did take a longer learning curve. However, once you have mastered it, its hard to figure what was so difficult - except remembering how to disingage the needle. Anyway, we have had great success with the catheter. We still have the insyte autoguard (BD) available but usage has changed from a 50 - 50 usage of each catheter (we used to use safti-imtima) to about 50-80 in favor of the Nexiva. It's used exclusively in our CT and other outpatient departments.
Regarding pain ... lido everytime.
Venous Access - Scripps Green Hospital